Barclays analyst Matt Miksic lowered the firm’s price target on Stryker (SYK) to $394 from $469 and keeps an Overweight rating on the shares. The company’s Q1 results were mixed and below Street estimates, the analyst tells investors in a research note. The firm cites the “significant back-end loaded ramp required” to achieve Stryker’s full year guidance for the target cut.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker price target raised to $361 from $357 at Goldman Sachs
- Stryker price target lowered to $385 from $437 at Baird
- Stryker price target lowered to $410 from $465 at Bernstein
- Stryker price target lowered to $355 from $365 at Evercore ISI
- Stryker price target lowered to $400 from $445 at JPMorgan